Chickpeas - disease management, MRZ Mid North


Research organisatons
Funding sources

Trial details

Researcher(s) Jason Brand and Tibebu Nigussie (DEDJTR), Christine Walela, Sarah Day, Amanda Pearce, Jenny Davidson, Andrew Ware and Larn McMurray (SARDI)
Year(s) 2016
Contributor Southern Pulse Agronomy
Trial location(s) Turretfield, SA
Chickpeas - disease management, MRZ Mid North locations
  • .To evaluate ascochyta blight (AB) response of new advanced varieties by comparing their susceptibility to commercial varieties
Key messages
  • Environmental conditions of wet weather favoured AB disease development and allowed for evaluation of virulence of disease and susceptibility of different chickpea varieties/lines.
  • The current trial established a change in susceptibility of AB pathogen in varieties previously rated as moderately resistant and resistant. This result indicates that there has been a change in virulence in the AB pathogen in chickpeas across SA. Consequently, this has resulted in all chickpea resistance ratings being revised to susceptible or moderately susceptible in the southern region.
  • Application of fortnightly foliar sprays with Chlorothalonil at the registered rate of 2 L/ha ahead of rain effectively controlled AB pathogen and benefited yields similarly across all varieties irrespective of their AB category. A cost benefit analysis of this continuous protection was not carried out in the current trial and therefore the profitability of this strategy will require further evaluation.
  • The current trial identified advanced breeding lines with improved level of AB resistance over the current commercial varieties such as Genesis™ 090 and PBA Slasher which are rated as being moderately resistant. These advanced breeding lines will be evaluated further and developed through our collaboration with Pulse Breeding Australia.
  • Overall, chickpea production in the southern region will require close monitoring of disease together with adapting an integrated disease management strategy that incorporates agronomic practices including use of AB free seed, variety selection, use of thiram-based seed treatments and multiple foliar fungicides, maintaining adequate crop rotations with non-host crops and maintaining adequate distance from previous chickpea crops.
Lead research organisation Department of Economic Development, Jobs, Transport and Resources VIC
Host research organisation N/A
Trial funding source SARDI
Trial funding source GRDC DAV00150
Related program Southern Pulse Agronomy

We are grateful for the support we receive from the numerous commercial agronomists and seed commercialising companies.

Technical Support :

  • Jason Ellifson, Russel Argall, Ash Purdue, Mick Brady, Chris Davies (DEDJTR), Henk Venter, Cathy Fisher, Lee Davis, John Nairn (Clare, SA) and Leigh Davis (Minnipa Ag Centre, SA)

Industry Collaborators :

  • Matt Rodda, Garry Rosewarne and Helen Richardson (DEDJTR), Kristy Hobson (DPI NSW), Jeff Paull (University of Adelaide), Jenny Davidson, Rohan Kimber, (SARDI), Ashley Wallace (Regional Research Agronomist Program) and Southern Farming Systems for managing trials in SW Vic.

Other trial partners Not specified
Download the trial report to view additional trial information


Crop type Chickpeas
Treatment type(s)
  • Fungicide
  • Fungicide: Type
  • Fungicide: Application
  • Variety: Type
Trial type Experimental
Trial design Replicated

Turretfield 2016

Sow rate or Target density Desi = 50 plants/m2, Kabula = 35 plants/m2
Sowing machinery

22.5cm row spacing

Sow date 16 May 2016
Harvest date Not specified
Plot size 10m x 1.75m
Plot replication Not specified

MAP + Zn (2%) @ 90 kg/ha at sowing


Fortnightly fungicide application (Chlorothalonil @ 2L/ha) and Nil/unprotected.

Seed treatment P-Pickel T (200 ml/100kg seed)
Inoculant All treatments were inoculated with AB spores at early seedling growth of 3 to 4 node growth stage
Download the trial report to view additional method/treatment information

Individual Trial Project data and information and OFT metadata are licensed under a Creative Commons Attribution 4.0 International License.
The data and information accessed through OFT may also be subject to Terms of Use specified by the Trial Contributor,
in which case the Terms of Use of a Trial Contributor take precedence over other information provided on OFT.
Trial last modified: 24-07-2019 12:11pm AEST